Literature DB >> 1986378

Reassociation with beta 2-microglobulin is necessary for Db class I major histocompatibility complex binding of an exogenous influenza peptide.

K L Rock1, S Gamble, L Rothstein, B Benacerraf.   

Abstract

A synthetic peptide corresponding to residues 365-380 of the influenza nucleoprotein (NP365-380) has been previously shown to associate with class I major histocompatibility complex-encoded molecules and to stimulate cytotoxic T lymphocytes [Townsend, A. R. M., Rothbard, J., Gotch, F. M., Bahadur, G., Wraith, D. & McMichael, A. J. (1986) Cell 44, 959-968]. We find that intact Db class I heterodimers on the cell surface are unreceptive to binding this antigen. However, NP365-380 readily associates with Db molecules on the plasma membrane in the presence of exogenous beta 2-microglobulin. In addition, there is a second pathway through which this peptide associates with class I molecules that requires energy and de novo protein synthesis. These findings have implications for maintaining the immunological identity of cells and for the use of peptides as vaccines for priming cytolytic T-cell immunity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986378      PMCID: PMC50798          DOI: 10.1073/pnas.88.1.301

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

2.  Assembly of MHC class I molecules analyzed in vitro.

Authors:  A Townsend; T Elliott; V Cerundolo; L Foster; B Barber; A Tse
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

Review 3.  The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site.

Authors:  G Gammon; N Shastri; J Cogswell; S Wilbur; S Sadegh-Nasseri; U Krzych; A Miller; E Sercarz
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

Review 4.  Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes.

Authors:  T J Braciale; L A Morrison; M T Sweetser; J Sambrook; M J Gething; V L Braciale
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

Review 5.  T-cell recognition of lysozyme: the biochemical basis of presentation.

Authors:  P M Allen; B P Babbitt; E R Unanue
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

6.  Introduction of soluble protein into the class I pathway of antigen processing and presentation.

Authors:  M W Moore; F R Carbone; M J Bevan
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

7.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

8.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

9.  Cells process exogenous proteins for recognition by cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink; Y Hosaka
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

10.  Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.

Authors:  F R Carbone; M W Moore; J M Sheil; M J Bevan
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  13 in total

1.  Analysis of the association of peptides of optimal length to class I molecules on the surface of cells.

Authors:  K L Rock; L Rothstein; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

Review 2.  Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Authors:  Sven Brode; Paul A Macary
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

3.  Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules.

Authors:  L D Falo; L J Colarusso; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

4.  Low temperature and peptides favor the formation of class I heterodimers on RMA-S cells at the cell surface.

Authors:  K L Rock; C Gramm; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

5.  An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule.

Authors:  H Hörig; N J Papadopoulos; Z Vegh; E Palmieri; R H Angeletti; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin.

Authors:  L F Boyd; S Kozlowski; D H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 7.  The pathogenetic aspects of spondyloarthropathies from the point of view of HLA-B27.

Authors:  H Kellner; D Yu
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

8.  A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity.

Authors:  M G Mage; L Lee; R K Ribaudo; M Corr; S Kozlowski; L McHugh; D H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.

Authors:  Lolke De Haan; Arron R Hearn; A Jennifer Rivett; Timothy R Hirst
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

10.  Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced.

Authors:  J J Boniface; D S Lyons; D A Wettstein; N L Allbritton; M M Davis
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.